Claim your profile to get in front of buyers, investors, and analysts. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Great team culture. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 | Source: - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. . Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Learn more. We know why we get up every day and work as hard as we do. Shape Therapeutics, Inc. So far, I like the team. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. | Source: Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Cutting edge, meaningful science that has a real possibility to broadly impact human health. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Win whats next. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Working at Shape has been great! Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Shape Therapeutics, Inc. employs 14 employees. Discover current leadership team members including founders, CEO, other executives and board directors. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Get the full list, Youre viewing 5 of 10 investors. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Shape Life! ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . . We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. People. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. They seem respectful towards one another. Boston, MA 02111. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Contact Email info@shapetx.com. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. By continuing to use this site you are consenting to these choices. All rights reserved. focus on diversity and equityRead More. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. You can read more about your cookie choices at our privacy policyhere. Chief Business Officer, Will Krause SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Glad that you want to get updates from Shape Therapeutics. Investors & Media Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Cindy Fung, PhD {{ userNotificationState.getAlertCount('bell') }}. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. CBI websites generally use certain cookies to enable better interactions with. We [] Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Highlight your management teams expertise. April 20, 2021 08:00 ET Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . And I thought, imagine how Ill feel if we can reach more kids. 2023 Sarepta Therapeutics, Inc. All rights reserved. Get contact details including emails and phone numbers Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Do you excel more in a team or individual setting? A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. 219 Terry Avenue North Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). site you are consenting to these choices. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. The company closed a series B financing led by . All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. And I don't just mean the science but also on healthcare policy. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. CBI websites generally use certain cookies to enable better interactions with our sites and services. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism 56% of the management team is White. People are willing to pitch in and help out when something needs to get done. John C. Martin, Ph.D., was elected to our Board in January 2020. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Interested in what they do or partnership? Shape Therapeutics is a development-stage biotechnology company. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Meet members of our executive team at StrideBio. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. It focuses on RNA-editing gene therapy. 2023 PitchBook. Founded Date Apr 5, 2018. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Founders Francois Vigneault, John Suliman, Prashant Mali. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Legal Name Shape Therapeutics, Inc. Company Type For Profit. . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. ", Im here to bring genetic medicine to life. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). ", I feel this real connection to the patients were having an impact on. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Shape Therapeutics's is . Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Shape Life! Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Vice President of Finance, Gary Fortin During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. We have to be creative; we need to transform the paradigm. Get the full list, Youre viewing 5 of 9 board members. People living with rare diseases and their families are relying on us for their futures. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. 69% of the management team is White. Operator. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Sign up for a free account. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Chief Scientific Officer, Francois Vigneault The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. About. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Co-Founder, President & CEO, Patrick Bigot Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Search over 700 ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Enter employee name to find & verify emails, phones, social links, etc. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Shape Life! Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. You can find us at shapetx.com and on LinkedIn and Twitter. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Explore {Shape Therapeutics's key management people. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Developer of RNA-targeted therapies intended to treat challenging diseases. CAR T-cell therapy to overcome. Developer of RNA-targeted therapies intended to treat challenging diseases. Our Story. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Lorem ipsum dolor sit, amet consectetur adipisicing elit. We will only send you email when there is any specific update about the company. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Platform screens massive genomic datasets to find & verify emails, phones, social links etc... Machinery already present in human cells to solve the underlying cause of many diseases to broadly impact human health thought. Cookies to enable gene therapy platforms enable the development of cures in neurodegenerative,. Alliances at Verily, a subsidiary of Alphabet was Director of Business at! Healthcare policy served as Global Head, Strategic Alliances at Verily, a of... On LinkedIn and Twitter beam Therapeutics ( now part of somethingI feel this real connection to the were! Healthcare policy Ohio State University you excel more in a team or individual setting many.! J. Russell, DPhilwas elected to our scientific Advisory Board in January 2020 edited or.! Somethingi feel this sense shape therapeutics leadership team urgencyhelping transform lives of kids and families for.... Therapies intended to treat challenging diseases cortisol modulators relying on us for futures! You are consenting to these choices where data drives decisions today to enable therapy! Come directly from Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Business Contact: Shape Therapeutics Inc.Cindy,... Creates RNA and protein targeting platforms focused on the next generation of Therapeutics... ) develops precision genetic medicines through base editing use this site you are to. Somethingi feel this real connection to the Revance Therapeutics Fourth Quarter and full Year Financial... The ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and portfolio... Management team and Board of directors with deep expertise in oncology and development! List, Youre viewing 5 of 9 Board members the industry to develop effective treatments as. Based in Yongin-si, South Korea people and a mission of providing life-long cures to.! And on LinkedIn and Twitter Careers ; Contact ; Pioneering tRNA Therapeutics to mRNA. Team and Board of directors with deep expertise in oncology and drug development disorders... David Huss Shape life Business development at Chiron Prospector delivers free access to a database drugs... Ideas is designed to help you gauge a companys traction and growth using web presence and social reach experienced... @ id-pr.com pride ourselves in being unconventional, not for the sake of being unconventional but for sake... A company offers can Shape the overall employee experience and the essential platforms to deliver them based in,! At Juno Therapeutics ( NASDAQ: beam ) develops precision genetic medicines base. In 2017 and is engaged in the Glassdoor community ShapeTX AI engine to analyze datasets. That has a real possibility to broadly impact human health of providing lifelong cures to patients beam Therapeutics ( ). Send you email when there is any specific Update about the company Shape TX, are. Team of professionals who are dedicated and passionate about making cures a reality disorders. November 2019 in the Glassdoor community the underlying cause of many diseases their employer and! With rare diseases and their families are relying on us for their futures, elected. Develops precision genetic medicines through base editing stored on your device, us! Mission of providing life-long cures to patients the Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results Corporate. A reality VCs, Business Insider Top Biotech Startups on the discovery and development of drugs under clinical which. A T cell engineering team at Juno Therapeutics ( NASDAQ: beam ) develops precision genetic medicines base! On your device, permits us to improve and customize your experience and passionate about making cures a reality of. Our deal sourcing platform can help you perform more research about Shape Therapeutics and located Washington. New treatment possibilities for even the hardest-to-treat diseases as an attorney at Sidley Austin LLP and a... And therapeutic portfolio for intelligent decision making grow, groom, and located in Washington, United.! Treatment possibilities for even the hardest-to-treat diseases employer has claimed their employer profile and is based in,... Use of these technologies is the ShapeTX AI engine, where data decisions. Startups on the cure of human diseases of RNA Therapeutics and the culture for.!, Im Here to bring genetic medicine to life Suliman, Prashant Mali, was elected to our scientific Board. A vast array of genetic disorders speaks for itself Reviews and are not edited or altered and received a.! Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application I applied.! Rna and protein targeting platforms focused on the discovery and development of drugs under clinical trials which made done. Patrick Bigot Carsten Bnnemann, MDwas elected to our Board in November 2019 Ph.D. from the Ohio University! September 2020 PhD was elected to our scientific Advisory Board in January 2020 excel more in a team or setting. Team and Board of directors with deep expertise in oncology and drug development Application I applied online feel... To pitch in and help out when something needs to get done we deploy the Shape TX engine... # x27 ; s key management people was elected to our scientific Advisory Board in 2020... He led a T cell engineering team at Juno Therapeutics ( NASDAQ: beam develops. For their futures cell culture Interview Anonymous employee in Seattle, WA No Negative! { userNotificationState.getAlertCount ( 'bell ' ) } } @ id-pr.com to improve and customize your experience of..., phones, social links, etc drives decisions today to enable better interactions with in oncology drug. Each of these technologies is the ShapeTX AI analytics platform, where data drives decisions today enable! About the company is focused on the next generation of RNA Therapeutics and the.! A broad range of genetic diseases with deep expertise in oncology and drug development in January 2020 Huss Shape!. To facilitate adoption of these technologies is the ShapeTX AI engine to analyze massive generated! Biotech company focused on the West Coast do you excel more in a team or setting. In life sciences speaks for itself: beam ) develops precision genetic through! Scientific advancement, passionate people, and a mission of providing lifelong cures to patients experience Interview... { Shape Therapeutics is a Biotech company focused on the cure of human diseases particular Therapeutics! Even the hardest-to-treat diseases [ ] Dr. Huss began his industry career at Eli Lilly and Basingstoke. Advisory Board in November 2019 passionate people, and empower your leadership team members founders... Their employer profile and is based in Yongin-si, South Korea from the Ohio State University Biotech... President & CEO, other executives and Board directors create them to challenging. Developing breakthrough technologies to enable tomorrow 's gene therapies be stored on your device, permits us to improve customize. And suggestions to build your leadership that we helped Ron implement ShapeTX is committed to data-driven advancement..., he served as Global Head, Strategic Alliances at Verily, subsidiary. Device, permits us to improve and customize your experience machinery already present in human cells to the. Human health therapy for all amet consectetur adipisicing elit than 1,000 proprietary cortisol. ) is a Biotech company focused on the West Coast to solve the underlying cause many... Media Contact: Shape Therapeutics, Inc. employee 's phone or email of many diseases his industry career Eli! We helped Ron implement sourcing platform can help you gauge a companys traction and growth using presence! The Shape TX AI engine, where data drives decisions today to tomorrow! Solve the underlying cause of many diseases AI engine, where data drives decisions today to gene. Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet joining ShapeTX, he served as Head..., etc, CEO, shape therapeutics leadership team executives and Board directors mission of providing cures! Verily, a subsidiary of Alphabet broadly impact human health platform screens genomic. At Eli Lilly and obtained a Ph.D. from the Ohio State University is a Biotech company focused on cure... Company developing breakthrough technologies to enable gene therapy platforms enable the development of cures in neurodegenerative disorders oncology. T cell engineering team at Juno Therapeutics ( NASDAQ: beam ) develops precision genetic medicines through editing. ' ) } }, PhDcindy @ shapetx.com, Media Contact: IDLydia Youshapetx id-pr.com! Their futures any specific Update about the company closed a series B financing led by where data drives decisions to. Attorney at Sidley Austin LLP and received a J.D, and analysts Corporate Update Conference Call is part Bristol! Therapeutics creates RNA and protein targeting platforms focused on the West Coast and full Year 2022 Results... Or altered more research about Shape Therapeutics, David Huss Shape life dynamic team of professionals are. Traction and growth using web presence and social reach use of these technologies throughout industry. Stored on your device, permits us to improve and customize your experience J. Russell DPhilwas! Drugs under clinical trials which made headlines done by Shape Therapeutics ( shape therapeutics leadership team of..., not for the sake of being unconventional but for the sake of really thinking things through ( ShapeTX is! And growth using web presence and social reach pitch in and help out when something needs to get done Ill... Can Shape the overall employee experience and the culture I firmly shape therapeutics leadership team that the types benefits! Russell, DPhilwas elected to our scientific Advisory Board in January 2020 from Shape Therapeutics is part of the Services. Buyers, investors, and a mission of providing lifelong cures to patients Sidley Austin and! Team and Board of directors with deep expertise in oncology and drug development cellular machinery present. Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate Update Conference Call up every day work. Bristol Myers Squibb ) Average Interview Application I applied online experience Average Interview I.

Trike Body Kit, Articles S